2005Chinese Journal of Blood PurificationRequires access

A report of 130 severe hepatitis cases treated with artificial liver support system

Ying Deng

Open publisher page 0 citations

Abstract

Objective To evaluate the therapeutic effect, the treatment time, and the incidence of side effect of artificial liver support system (ALSS) the treating severe hepatitis. Methods Two hundred and fifty-two patients with severe hepatitis were randomly divided into the treatment group (130 cases) and the control group (122 cases). Comprehensive liver-protecting therapy was given to all patients in two groups. Additionally, ALSS was given to the treatment group simultaneously. The therapeutic effects and side effects of ALSS in patients of different stages were observed. Results The general effective rate of the treatment group was 72.30%.And the effective rate for early, middle and late stage patients in the treatment group were 97.87%, 82.00%, and 30.30% respectively. The general effective rate for the control group was 52.46%. And the effective rate for early, middle and late stage patients in the control group were 69.64%, 53.66%, and 12.00% respectively. There was significant difference between these two groups in effective rates (P 0.001). Six hundred and seventy casetimes of ALSS was used in the treatment group. The side effects of ALSS occurred 62 case-times. And the incidence of side effects was 9.25%. Conclusion ALSS is an effective and safe way for the treatment of patients with severe hepatitis, especially for patients in early or middle stage.

About this research paper

What this paper is about

Objective To evaluate the therapeutic effect, the treatment time, and the incidence of side effect of artificial liver support system (ALSS) the treating severe hepatitis. Methods Two hundred and fifty-two patients with severe hepatitis were randomly divided into the treatment group (130 cases) and the control group (122 cases). Comprehensive liver-protecting therapy was given to all patients in two groups. Additionally, ALSS was given to the treatment group simultaneously. The therapeutic effects and side effects of ALSS in patients of different stages were observed. Results The general effective rate of the treatment group was 72.30%.And the effective rate for early, middle and late stage patients in the treatment group were 97.87%, 82.00%, and 30.30% respectively. The general effective rate for the control group was 52.46%. And the effective rate for early, middle and late stage patients in the control group were 69.64%, 53.66%, and 12.00% respectively. There was significant difference between these two groups in effective rates (P 0.001). Six hundred and seventy casetimes of ALSS was used in the treatment group. The side effects of ALSS occurred 62 case-times. And the incidence of side effects was 9.25%. Conclusion ALSS is an effective and safe way for the treatment of patients with severe hepatitis, especially for patients in early or middle stage.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the therapeutic effect, the treatment time, and the incidence of side effect of artificial liver support system (ALSS) the treating severe hepatitis. Methods Two hundred and fifty-two patients with severe hepatitis were randomly divided into the treatment group (130 cases) and the control group (122 cases). Comprehensive liver-protecting therapy was given to all patients in two groups. Additionally, ALSS was given to the treatment group simultaneously. The therapeutic effects and side effects of ALSS in patients of different stages were observed. Results The general effective rate of the treatment group was 72.30%.And the effective rate for early, middle and late stage patients in the treatment group were 97.87%, 82.00%, and 30.30% respectively. The general effective rate for the control group was 52.46%. And the effective rate for early, middle and late stage patients in the control group were 69.64%, 53.66%, and 12.00% respectively. There was significant difference between these two groups in effective rates (P 0.001). Six hundred and seventy casetimes of ALSS was used in the treatment group. The side effects of ALSS occurred 62 case-times. And the incidence of side effects was 9.25%. Conclusion ALSS is an effective and safe way for the treatment of patients with severe hepatitis, especially for patients in early or middle stage.

Key concepts: Medicine, Artificial liver, Hepatitis a virus, Incidence (geometry), Stage (stratigraphy), Internal medicine, Therapeutic effect, Hepatitis

Related papers

Back to paper searchBrowse research topicsOriginal source
A report of 130 severe hepatitis cases treated with artificial liver support system — Research Paper | ScholarLens